s6y
Company name or ticker
Search
Checkmate Pharmaceuticals, Inc.
8-K
Current report filing
Filed
Tuesday, December 8, 2020
Period
Dec 7, 2020
Accession number
0001193125-20-312717
Documents
8-K
8-K
EX-99.1
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header